A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC

NCT05611671 · clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
280
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)